AzTrials
AzTrials

Total Knee ArthroplastyNCT06196359

Assessing Function and Pain After Total Knee Arthroplasty With Combined Femoral and Popliteal Nerve Block

A study testing Combined Femoral and Popliteal nerve block in people with Total Knee Arthroplasty and Total Knee Replacement, run by University of Haifa at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this interventional study is to examine whether a pain management technique of combined femoral and popliteal nerve block is effective in total knee arthroplasty patients. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Combined Femoral and Popliteal nerve block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteIsrael
Study dates
1 Nov 2022to 14 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Over the age of 18
  • Electively assigned for primary knee replacement surgery.
  • The American Society of Anesthesiologists physical status score 1-3.

Who cannot join

  • Revision surgery.
  • Patients suffering from chronic pain syndrome or chronic opioid use.
  • Patients with previous neurological deficits in the lower extremities.
  • A cognitive state that does not allow signing of consent or understanding simple instructions.

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Galilee Medical Centre

    Nahariya, 22000

Other trials in Israel

About this study

The goal of this interventional study is to examine whether a pain management technique of combined femoral and popliteal nerve block is effective in total knee arthroplasty patients. The main questions it aims to answer are:

Are there differences in postoperative outcomes? Does the nerve block, age, preoperative quadriceps muscle strength and Oxford Knee Score of the patient predict early functional ability? Participants underwent total knee arthroplasty and assessments. Researchers compared pain management techniques to assess effects on postoperative outcomes and identified the importance of preoperative variables a predictors of early functional ability. Further research is required to refine postoperative pain management strategies.

Being tested
Combined Femoral and Popliteal nerve block

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combined Femoral and Popliteal nerve blockProcedure or surgery

    Patients who receive a combined femoral and popliteal nerve block during surgery, fill out a questionnaire and undergo a muscle strength test before surgery, undergo functional tests, a muscle strength test and are asked about pain intensity after surgery.

Study groups in NCT06196359
Study groupRoleWhat they receive
Combined Femoral and Popliteal nerve blockExperimentalPatients who receive a Patients undergoing total knee arthroplasty received a combined femoral and popliteal nerve block (single-shot of each) during the surgical procedure.
Receives: Procedure: Combined Femoral and Popliteal nerve block
Control groupNo interventionPatients undergoing total knee arthroplasty and didn\'t receive pain block.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Timed up & go Test

    Total time to arise from chair, walk 3 m, turn around, return to chair and sit down. Two trials performed and the faster of the two is recorded to the nearest 10th of a second.

    Measured: First day after surgery and third or fourth day after surgery

  2. Numeric Pain Rating Scale

    An 11-point scale scored from 0 to 10: 0 = no pain, 10= the most intense pain imaginable

    Measured: up to four days after surgery

  3. Quadriceps Muscle Strength

    muscle strength measure by dynamometer (N⋅m)

    Measured: A 1 day before the surgery, first day after the surgery and third or fourth day after the surgery .

Secondary outcomes (7)
  1. Elderly Mobility Scale

    The Elderly Mobility Scale is a 20 point validated assessment tool for the assessment of frail elderly subjects. The The Elderly Mobility Scale is measured on an ordinal scale of 0-20, when Scores under 10 - generally these patients are dependent in mobility maneuvers; require help with basic activity of daily living, such as transfers, toileting and dressing. Scores between 10 - 13 - generally these patients are borderline in terms of safe mobility and independence in activity of daily living i.e. they require some help with some mobility maneuvers. Scores over 14 - Generally these patients are able to perform mobility maneuvers alone and safely and are independent in basic activity of daily living.

    Measured: First day after the surgery and third or fourth day after the surgery

  2. 5 Times Sit to Stand Test

    The score is the amount of time (to the nearest decimal in seconds) it takes a patient to transfer from a seated to a standing position and back to sitting five times.

    Measured: First day after the surgery and third or fourth day after the surgery

  3. Hospitalization Duration

    Number of days of hospitalization after the surgery- taken from the pa...

    Measured: At discharge (assessed up to day 10)

  4. Surgery Duration

    minutes- taken from the patient's file

    Measured: During the surgery

  5. Consumption of Analgesics

    taken from the patient's file

    Measured: At discharge (assessed up to day 10)

  6. Occurrence of Falls

    throughout the hospitalization- taken from the patient's file

    Measured: At discharge (assessed up to day 10)

  7. Oxford Knee Score Questionnaire

    The Oxford Knee Score is a patient self-completion patient-reported outcome containing 12 questions on activities of daily living. It provides a single summed score which reflects the severity of problems that the respondent has with their knee. The Oxford Knee Score is scored 0-48 when Score 0-19 May indicate severe knee arthritis. Score 20-29 May indicate moderate to severe knee arthritis. Score 30-39 May indicate mild to moderate knee arthritis. Score 40-48 May indicate satisfactory joint function.

    Measured: A 1 day before the surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2024
  2. Study start1 Nov 2022
  3. Primary completion14 Jul 2023
  4. Study completion14 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06196359
Sponsor's protocol ID
UHaifa-FPNB
Status last verified
Dec 2023
First submitted
25 Dec 2023
Last updated
12 Jan 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Combined Femoral and Popliteal nerve block in people with Total Knee Arthroplasty and Total Knee Replacement, run by University of Haifa at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Timed up & go Test (time frame: First day after surgery and third or fourth day after surgery). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in